These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 11117923)
1. New risk factor for HIV-1 might be blessing in disguise. Morris K Lancet; 2000 Nov; 356(9244):1827. PubMed ID: 11117923 [No Abstract] [Full Text] [Related]
2. Basal RANTES promoter activity differs considerably among different species of monkeys: implications for HIV-1/AIDS progression. Sood V; Gupta N; Shanker V; Bano AS; Banerjea AC AIDS; 2007 Jan; 21(1):116-8. PubMed ID: 17148981 [No Abstract] [Full Text] [Related]
3. [Preliminary study on the association of chemokine RANTES gene polymorphisms with HIV-1 infection in Chinese Han population]. Liu XL; Wang FS; Jin L; Liu MX; Xu DZ Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov; 24(11):971-5. PubMed ID: 14687494 [TBL] [Abstract][Full Text] [Related]
4. Association of RANTES -403 G/A, -28 C/G and In1.1 T/C polymorphism with HIV-1 transmission and progression among North Indians. Rathore A; Chatterjee A; Sivarama P; Yamamoto N; Singhal PK; Dhole TN J Med Virol; 2008 Jul; 80(7):1133-41. PubMed ID: 18461620 [TBL] [Abstract][Full Text] [Related]
5. Protective effects of IL4-589T and RANTES-28G on HIV-1 disease progression in infected Thai females. Wichukchinda N; Nakayama EE; Rojanawiwat A; Pathipvanich P; Auwanit W; Vongsheree S; Ariyoshi K; Sawanpanyalert P; Shioda T AIDS; 2006 Jan; 20(2):189-96. PubMed ID: 16511411 [TBL] [Abstract][Full Text] [Related]
6. Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. Moriuchi H; Moriuchi M; Fauci AS J Immunol; 1997 Apr; 158(7):3483-91. PubMed ID: 9120310 [TBL] [Abstract][Full Text] [Related]
7. Effects of single nucleotide polymorphisms in the RANTES promoter region in healthy and HIV-infected indigenous Chinese. Zhao XY; Lee SS; Wong KH; Chan KC; Ma S; Yam WC; Yuen KY; Ng MH; Zheng BJ Eur J Immunogenet; 2004 Aug; 31(4):179-83. PubMed ID: 15265023 [TBL] [Abstract][Full Text] [Related]
8. RANTES polymorphism affects susceptibility to HIV and asthma. Marshall H Trends Immunol; 2001 Jan; 22(1):13. PubMed ID: 11286683 [No Abstract] [Full Text] [Related]
9. Allelic variants of human beta-chemokine receptor 5 (CCR5) promoter: evolutionary relationships and predictable associations with HIV-1 disease progression. Tang J; Rivers C; Karita E; Costello C; Allen S; Fultz PN; Schoenbaum EE; Kaslow RA Genes Immun; 1999 Sep; 1(1):20-7. PubMed ID: 11197301 [TBL] [Abstract][Full Text] [Related]
10. Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1. Liu H; Hwangbo Y; Holte S; Lee J; Wang C; Kaupp N; Zhu H; Celum C; Corey L; McElrath MJ; Zhu T J Infect Dis; 2004 Sep; 190(6):1055-8. PubMed ID: 15319853 [TBL] [Abstract][Full Text] [Related]
12. Analysis of CCR5, CCR2, SDF1 and RANTES gene polymorphisms in subjects with HIV-related PML and not determined leukoencephalopathy. Guerini FR; Delbue S; Zanzottera M; Agliardi C; Saresella M; Mancuso R; Maserati R; Marchioni E; Gori A; Ferrante P Biomed Pharmacother; 2008 Jan; 62(1):26-30. PubMed ID: 17560067 [TBL] [Abstract][Full Text] [Related]
13. Single nucleotide polymorphism of CC chemokine ligand 5 promoter gene in recipients may predict the risk of chronic graft-versus-host disease and its severity after allogeneic transplantation. Kim DH; Jung HD; Lee NY; Sohn SK Transplantation; 2007 Oct; 84(7):917-25. PubMed ID: 17984846 [TBL] [Abstract][Full Text] [Related]
14. Gene polymorphisms in CCR5, CCR2, SDF1 and RANTES among Chinese Han population with HIV-1 infection. Li H; Liu TJ; Hong ZH Infect Genet Evol; 2014 Jun; 24():99-104. PubMed ID: 24650919 [TBL] [Abstract][Full Text] [Related]
15. CCL5/RANTES chemokine gene promoter polymorphisms are not associated with atopic and nonatopic asthma in a Spanish population. Muro M; Marín L; Torio A; Pagan JA; Alvarez-López MR Int J Immunogenet; 2008 Feb; 35(1):19-23. PubMed ID: 18186796 [TBL] [Abstract][Full Text] [Related]
16. Health agencies update: Genes and HIV infection. Stephenson J JAMA; 2000 Dec; 284(23):2987. PubMed ID: 11145538 [No Abstract] [Full Text] [Related]
17. RANTES production from CD4+ lymphocytes correlates with host genotype and rates of human immunodeficiency virus type 1 disease progression. Paxton WA; Neumann AU; Kang S; Deutch L; Brown RC; Koup RA; Wolinsky SM J Infect Dis; 2001 Jun; 183(11):1678-81. PubMed ID: 11343219 [TBL] [Abstract][Full Text] [Related]
18. Chemokines in human immunodeficiency virus (HIV) infection. Giovannetti A; Pierdominici M Indian J Med Res; 2008 Feb; 127(2):110-3. PubMed ID: 18403787 [No Abstract] [Full Text] [Related]
19. Polymorphisms in the 3' untranslated region of the fractalkine (CX3CL1) gene and the risk of HIV-1 infection and disease progression. Peraire J; Vidal F; Plana M; Domingo P; Coll B; Viladés C; Garcia F; Veloso S; Gatell JM; Broch M AIDS; 2007 Apr; 21(7):891-3. PubMed ID: 17415055 [No Abstract] [Full Text] [Related]
20. Decreasing sensitivity to RANTES (regulated on activation, normally T cell-expressed and -secreted) neutralization of CC chemokine receptor 5-using, non-syncytium-inducing virus variants in the course of human immunodeficiency virus type 1 infection. Koning FA; Kwa D; Boeser-Nunnink B; Dekker J; Vingerhoed J; Hiemstra H; Schuitemaker H J Infect Dis; 2003 Sep; 188(6):864-72. PubMed ID: 12964118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]